| Secondary |
| Hypertension |
27.1% |
| Drug Use For Unknown Indication |
20.0% |
| Cardiovascular Disorder |
8.6% |
| Depression |
5.7% |
| Product Used For Unknown Indication |
5.7% |
| Accidental Exposure |
4.3% |
| Diabetes Mellitus |
3.6% |
| Ill-defined Disorder |
3.6% |
| Colon Cancer |
2.9% |
| Atrial Fibrillation |
2.1% |
| Hyperlipidaemia |
2.1% |
| Parkinson's Disease |
2.1% |
| Tachycardia |
2.1% |
| Arrhythmia |
1.4% |
| Back Pain |
1.4% |
| Blood Pressure Increased |
1.4% |
| Cardiac Disorder |
1.4% |
| Coronary Artery Disease |
1.4% |
| Dyspnoea |
1.4% |
| Hypothyroidism |
1.4% |
|
| Vomiting |
22.0% |
| Hypotension |
6.8% |
| Stevens-johnson Syndrome |
6.8% |
| Syncope |
6.8% |
| Malaise |
5.1% |
| Medication Error |
5.1% |
| Pneumonia |
5.1% |
| Respiratory Failure |
5.1% |
| Circulatory Collapse |
3.4% |
| Coronary Artery Disease |
3.4% |
| Drug Ineffective |
3.4% |
| Foetal Growth Retardation |
3.4% |
| Hypoglycaemic Coma |
3.4% |
| Mucosal Inflammation |
3.4% |
| Pruritus |
3.4% |
| Psoriasis |
3.4% |
| Renal Failure Acute |
3.4% |
| Vertigo |
3.4% |
| Atrioventricular Block |
1.7% |
| Blood Pressure Increased |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.9% |
| Hypertension |
19.7% |
| Drug Use For Unknown Indication |
12.3% |
| Diabetes Mellitus |
5.5% |
| Prophylaxis |
4.0% |
| Atrial Fibrillation |
4.0% |
| Rheumatoid Arthritis |
3.6% |
| Coronary Artery Disease |
2.7% |
| Thrombosis Prophylaxis |
2.3% |
| Non-small Cell Lung Cancer |
2.2% |
| Cardiac Failure |
2.1% |
| Cardiac Disorder |
2.0% |
| Pain |
1.8% |
| Osteoporosis |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Depression |
1.4% |
| Hyperlipidaemia |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Multiple Myeloma |
1.2% |
| Anaemia |
1.2% |
|
| Vomiting |
14.1% |
| Thrombocytopenia |
8.5% |
| Urinary Tract Infection |
7.1% |
| Myocardial Infarction |
6.8% |
| Weight Decreased |
6.2% |
| Pneumonia |
5.9% |
| Tachycardia |
4.7% |
| Renal Failure |
4.4% |
| Hypertensive Crisis |
4.1% |
| Weight Increased |
4.1% |
| Cerebrovascular Accident |
3.8% |
| Pulmonary Embolism |
3.8% |
| Angina Pectoris |
3.5% |
| Death |
3.5% |
| Hypertension |
3.2% |
| Hypotension |
3.2% |
| Myalgia |
3.2% |
| Oedema Peripheral |
3.2% |
| Pain In Extremity |
3.2% |
| Pyrexia |
3.2% |
|
| Interacting |
| Hypertension |
20.7% |
| Product Used For Unknown Indication |
20.7% |
| Atrial Fibrillation |
18.5% |
| Pneumonia |
5.4% |
| Essential Hypertension |
4.3% |
| Gout |
3.3% |
| Hormone Therapy |
3.3% |
| Renal Failure Chronic |
3.3% |
| Atrial Flutter |
2.2% |
| Bacterial Infection |
2.2% |
| Cardiac Disorder |
2.2% |
| Cardiac Failure |
2.2% |
| Cardiac Failure Congestive |
2.2% |
| Diabetes Mellitus |
2.2% |
| Seasonal Allergy |
2.2% |
| Abnormal Behaviour |
1.1% |
| Acute Myocardial Infarction |
1.1% |
| Antiandrogen Therapy |
1.1% |
| Arrhythmia |
1.1% |
| Cardiac Valve Prosthesis User |
1.1% |
|
| Syncope |
21.4% |
| Drug Interaction |
14.3% |
| Renal Failure |
14.3% |
| Blood Creatinine Increased |
7.1% |
| Joint Injury |
7.1% |
| Oliguria |
7.1% |
| Prothrombin Time Shortened |
7.1% |
| Pruritus |
7.1% |
| Thrombocytopenia |
7.1% |
| Ventricular Fibrillation |
7.1% |
|
